Blood pressure medication recalled: Check your pills

Key Points:

• Over 3,700 bottles of a blood pressure medication combining Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide have been recalled by Macleods Pharma USA due to failing dissolution tests, meaning the pills may not release their active ingredients properly.
• The FDA classified the recall as Class II, indicating the medication may cause reversible side effects with a small chance of more serious effects, though no specific side effects have been identified.
• The recall affects two bottle sizes (30-count and 90-count) with specific lot numbers (12251163A and 12251163B) and national drug codes (NDC 33342-246-07 and 33342-246-10); patients are advised to check their medication accordingly.
• Macleods' generic version is being recalled, but the FDA has not issued any recalls for the equivalent brand name drugs, Tribenzor or Benicar HCT.
• Patients unsure if their medication is affected should contact their pharmacy, especially if their bottle lacks the specified lot numbers; the recalled medication expires on May 31, 2027.